naltrexone has been researched along with Bacterial Overgrowth Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brook, JB; Goodman, B; Myers, TL; Weinstock, LB | 1 |
| Chopra, PJ; Guarino, AH; Myers, TL; Schwartz, OA; Walters, AS; Weinstock, LB; Younger, JW | 1 |
2 other study(ies) available for naltrexone and Bacterial Overgrowth Syndrome
| Article | Year |
|---|---|
Successful treatment of postural orthostatic tachycardia and mast cell activation syndromes using naltrexone, immunoglobulin and antibiotic treatment.
Topics: Adult; Anti-Bacterial Agents; Blind Loop Syndrome; Drug Therapy, Combination; Female; Humans; Immunoglobulins, Intravenous; Intestine, Small; Mastocytosis; Naltrexone; Narcotic Antagonists; Postural Orthostatic Tachycardia Syndrome | 2018 |
Identification and Treatment of New Inflammatory Triggers for Complex Regional Pain Syndrome: Small Intestinal Bacterial Overgrowth and Obstructive Sleep Apnea.
Topics: Blind Loop Syndrome; C-Reactive Protein; Complex Regional Pain Syndromes; Female; Humans; Inflammation Mediators; Middle Aged; Naltrexone; Pain Management; Pain Measurement; Rifamycins; Rifaximin; Sleep Apnea, Obstructive; Treatment Outcome | 2016 |